A Phase 2 Study to Assess the Safety and Efficacy of Intravitreal ONL1204 Ophthalmic Solution in Subjects With Mac-off Retinal Detachment
Clinical trial NCT05730218 · COMPLETED
Trial details
- NCT number
- NCT05730218
- Sponsor
- ONL Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-04
- Primary completion
- 2024-02-21
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.